Patents by Inventor Steven E. Shoelson

Steven E. Shoelson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Human CIS protein
    Publication number: 20030022311
    Abstract: Isolated nucleic acid encoding a human cytokine-inducible SH2-containing protein, protein obtainable from the nucleic acid, recombinant host cells transformed with the nucleic acid and use of the protein and nucleic acid sequence are disclosed.
    Type: Application
    Filed: October 1, 2002
    Publication date: January 30, 2003
    Inventors: Damien D. Dunnington, James D. Frantz, Steven E. Shoelson
  • Growth factor receptor-binding insulin receptor
    Patent number: 5840536
    Abstract: Isolated nucleic acid encoding a growth factor receptor binding protein-insulin receptor isoform, protein obtainable from the nucleic acid, recombinant host cells transformed with the nucleic acid and use of the protein and nucleic acid sequence are disclosed.
    Type: Grant
    Filed: July 9, 1997
    Date of Patent: November 24, 1998
    Inventors: Damien J. Dunnington, James D. Frantz, Steven E. Shoelson
  • Peptides having insulin autoantibody but not insulin receptor binding capacity
    Patent number: 5422339
    Abstract: A therapeutic agent that includes a purified peptide bound to a cytotoxic moiety, the peptide being specifically reactive with human insulin autoantibodies and non-reactive with human insulin cell surface receptor, is disclosed.
    Type: Grant
    Filed: March 14, 1994
    Date of Patent: June 6, 1995
    Assignee: Joslin Diabetes Center, Inc.
    Inventors: George S. Eisenbarth, Luis Castano, Steven E. Shoelson